Bio News
-
Bio News | Collaborations & Alliances | Industry News
Merrimack Receives $5M Milestone from Shire
Triggered by the sale of ONIVYDE in the first major non-European, non-Asian country09.24.18
-
Bio News | Facilities | Fill/Finish | Industry News | Trials & Filings
Symbiosis Secures FDA Approval
For its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK09.24.18
-
Bio News | Industry News | Promotions & Moves
PharmaBlock Appoints CTO
Dr. Shijie Zhang brings over 20 years of combined experience in medicinal chemistry, process chemistry, and API manufacturing09.24.18
-
Bio News | Facilities | Industry News
AGC Biologics Announces New Facility
The process development & manufacturing site will contain single-use bioreactors at the 500 and 2000L scale09.24.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Celltrion, Emory Sign Incubation Agreement
To support the research and development of new drug candidates for atherosclerosis09.24.18
-
Bio News | Collaborations & Alliances | Industry News
Sherpa Details Added Benefits After PCI Acquisition
Sherpa Clinical Packaging’s President, Mark Paiz, shares the added benefits the acquisition brings PCI's customersOnline Exclusives09.21.18
-
Bio News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Drug Discovery | Facilities | Fill/Finish | Industry News
BeiGene Selects GE’s KUBio
For large-scale production of its cancer monoclonal antibodies (mAbs)Videos
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Abzena Signs Cancer Research Pact with Tmunity Therapeutics
Abzena will humanize monoclonal antibodies using its Composite Human Antibody technology09.20.18
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Drug Development | Industry News
Just Biotherapeutics, Pandion Enter Product Devt. and Mfg. Agreement
Just will apply fully integrated technology platform to speed Pandion's candidates through development and into the clinic09.20.18
-
Analytical Services | Bio News | Bioanalytical Services | Collaborations & Alliances | Industry News | Information Technology
Supply Chain Wizard Selected to Implement OEE Tracker
By an unnamed top-ten Contract Development and Manufacturing Organization09.20.18
-
Bio News | Facilities | Industry News | Process Development
Thermo Fisher to Launch Global Customer Solution Centers
Will provide critical workflows and integrated solutions that help advance chromatography and mass spectrometry worldwide09.20.18
-
Bio News | Bioanalytical Services | Collaborations & Alliances | Industry News
Epicon Begins Operations
The joint venture between Avalon GloboCare Corp and Jiangsu Unicorn Biological Technology Co. occupies a 16,000 sq. ft. space09.20.18
-
Bio News | Biologics, Proteins, Vaccines | Collaborations & Alliances | Industry News | R&D
Oxford Genetics & ERS Genomics Extend Agreement
Their pre-existing non-exclusive, license agreement now includes the use of CRISPR gene editing technology in the APAC region09.20.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Propanc, University of Jaén, Spain Enter Collaboration
For the provision of research services and scientific technical advice for the Company's POP1 drug discovery program09.19.18
-
Bio News | Collaborations & Alliances | Industry News
Molecular Templates, Takeda Enter Agreement
For the joint development of CD38-targeted engineered toxin bodies (ETBs) for the treatment of patients with diseases09.19.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
APEIRON & LDC Enter Partnership
To perform drug discovery activities to optimize and develop novel small molecules addressing immune checkpoints09.19.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Dyadic, Sanofi in Research Collaboration
To explore the potential of its C1 technology to produce multiple types of biologic vaccines and drugs of interest09.18.18
-
Bio News | Collaborations & Alliances | Industry News
Neurimmune Achieves Milestone in Ono Collaboration
Focused on the development of human-derived antibodies against a novel therapeutic target for neurodegenerative diseases09.18.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Fate & ONO Enter Development Partnership
For the joint development and commercialization of two off-the-shelf CAR-T cell product candidates09.18.18
-
Bio News | Industry News | Promotions & Moves
Metrion Announces Executive Appointments
Dr Edward Stevens joins as head of Drug Discovery, and Dr Andrew Lightfoot as head of Medicinal Chemistry & Discovery Funding09.17.18
